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Significance of 
Pathophysiology 
     When dystrophin is affected by a 
mutation, it's function is compromised 
and several changes occur. Refer to the 
following list and chart for these 
changes (Kaspar et al, 2009): 
• the sarcolemma becomes fragile and 
susceptible to tears from muscle 
contraction (Kaspar et al, 2009) 
• extracellular calcium enters the 
muscle fiber  through tears(Kaspar et 
al, 2009) 
• calcium activated proteases are 
activated (Kaspar et al, 2009) 
• protein degradation occurs (Kaspar 
et al, 2009) 
• release of intracellular muscle 
proteins leads to increased creatine 
kinase (CK) levels in the blood (Kaspar 
et al, 2009) 
• gradual muscle cell unit death 
 and macrophage invasion (Do,  2014 
• dead muscle  is replaced by a fatty 
infiltrate and clinically appears as 
pseudohypertrophy  (Do, 2014) 
     The changes discussed, occur in all 
types of muscle all over the body, 
including cardiac muscle. Because 
cardiomyocytes contract many more 
times a day than skeletal muscle fibers 
do, the process is accelerated in cardiac 
muscle, leading to cardiomyocyte death 
and fibrosis and thus dilation of the 
heart (Kaspar et al, 2009).  
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Although no cure has been offered 
for this debilitating disease, patients 
who are affected by DMD can overcome 
many obstacles and still live a decent 
quality of life with current healthcare 
support. These patients continue to 
strive even though most odds are 
against them. Genetics cannot be 
altered at this point, but nurses can do a 
great deal else to help these patients. 
Nurses should have an understanding of 
the pathophysiology behind the DMD as 
well as be able to educate families on 
health maintenance and healthy 
practices that will prolong some 
complications of DMD. It is also 
important to remember these 
individuals may looks deteriorated on 
the outside, but they are of normal 
intelligence and need human interaction 
just as anyone else. Sometimes just 
spending a minute of time conversing 
with these individuals can mean all the 
world to them. It can be vey rewarding 
for nurses who care for these special 
patients. 
In Conclusion 
Duchenne Muscular Dystrophy (DMD) is 
an X-linked neuromuscular disorder 
characterized by progressive, generalized 
weakness, and wasting of muscle (Kaspar, 
Allen, & Monetnaro, 2009).  DMD is the most 
common form of childhood muscular 
dystrophy, and it affects  1 in every 4,000 
male newborns (Ruitin, Straub, Bushby, & 
Guglieri, 2014) Diagnosis is usually made 
between the ages of three and six and those 
with DMD do not typically live past the age of 
thirty (Kaspar et al, 2009). Because the 
appearance of symptoms usually emerge in 
the early childhood years, nurses typically 
have the chance to work closely with patients 
and families throughout disease course of 
DMD  
Introduction 
All types of muscular dystrophy involve a mutation affecting the dystrophin 
gene. The dystrophin gene is located on the short arm of chromosome X, close to 
p21 locus (Do,  2014). Different mutations result in different forms and 
severities  of muscular dystrophy.  Mutations that allow some expression of the 
dystrophin gene lead to less severe forms of muscular dystrophy, while 
mutations that are more severe and result in extremely low levels of 
dysfunctional dystrophin  cause DMD (Kaspar et al, 2009).  Two examples of 
mutations that result in DMD are those that interfere with the translation 
reading frame or promoter sequences; both of these mutations lead to unstable, 
ineffective proteins (Do, 2014).  
Overview of 
Pathophysiology 
     Young boys usually present with 
disordered or delayed motor 
development, muscle weakness, and 
possible speech delays in early childhood 
(Ruiten et al, 2014).  The first symptoms 
almost always show up prior to the age 
of six years.  Parents may notice their 
young child with DMD having a hard 
time standing up, walking, or climbing 
stairs, and many will eventually need a 
wheelchair to get around (Brennan, 
2014).  Initial blood tests obtained are 
remarkable for an elevated creatine 
kinase (CK) and then diagnosis is 
typically confirmed with a genetic test 
showing a mutation in the dystrophin 
gene (Ruiten et al, 2014). 
     Eventually with progressive muscle 
dysfunction, cardiac complications occur. 
Cardiomyopathy occurs in at least 90% 
of patients with DMD, but shows up at 
varying ages (Ashwath, Jacobs, Crowe, 
Ashwath, Super, & Bahler, 2014)  Most of 
these patients initially develop heart 
disease characterized by fibrosis in the 
basal inferolateral wall of the left 
ventricle and then the lateral free wall 
(Ashwath et al, 2014). 
     Some other symptoms that occur as 
DMD progresses include a waddling gait, 
walking on toes, scoliosis, shortness of 
breath, fatigue, difficulty concentrating, 
and problems with learning and 
memory. 
Although intelligence is not affected by 
DMD, some children develop learning 
disabilities or behavioral issues 
(Brennan, 2014). 
     Of note, DMD is not usually a painful 
disease process, although it can cause 
muscle cramping at times. Most of those 
affected maintain function of their 
bladder and bowel (Brennan, 2014). 
 
     As muscle units die and the total 
number of functional muscle units 
decreases, weakness occurs, and 
eventually leads to contractures (Do, 
2014). This process is responsible for 
the overt symptoms and gradual 
progression of the disease. This 
progression occurs in an ascending 
fashion, starting with minimal 
weakness, leads to a wheelchair bound 
patient, and ends up causing 
respiratory and cardiac failure in the 
end stages of the disease. (Do, 2014). 
Premature death often occurs in the 
second or third decade of life due to 
cardiac dysfunction and respiratory 
muscle weakness (Ashwath et al., 
2014). 
Many times patients with DMD are 
admitted with heart failure and respiratory 
failure once the muscles of these organ 
systems become too weak.  Although there 
is no cure, supportive therapy is available 
to help these patients live through 
complications of this disease process. New 
technology is also allowing these patients 
to have an increasingly normal life outside 
of the hospital.  These patients hold a very 
special place in  the hearts of many nurses. 
They overcome many hardships and still 
seem to be the most uplifting children and 
young adults. 
 
 
     Experts have identified, that a 
multidisciplinary approach to caring for 
those with DMD is key (Muscular 
Dystrophy Association, 2015).  As a 
professional nurse, it is important to 
advocate for a multidisciplinary team and 
continuity of care for a patient with DMD. 
The American Academy of Pediatrics 
recommends that DMD patients regular 
yearly evaluations, as well as evaluations 
when cardiac symptoms occur (Muscular 
Dystrophy Association, 2015).  Physical 
therapy is an important consult these 
patients should have. The primary goals 
of physical therapy are to prevent 
contractures and scoliosis, while allowing 
greater motion of joints (Muscular 
Dystrophy Association, 2015). 
      As with most diseases, one of the 
greatest services a nursing professional 
can offer is support for the patient and 
family. Being a source of support or 
consulting others for support is an 
important part of caring for a patient 
with DMD, especially in the early stages. 
Other families living with DMD can be 
good resources for families with a new 
diagnosis; local support groups and 
online discussion boards can be excellent 
tools for a nursing professional to provide 
(Brennan, D., 2015) 
     Education can also play a big factor in 
supporting families  of patients with 
DMD. It is important that patients with 
DMD stand and walk on a regular basis 
and stay active while possible; this keeps 
bones strong, the spine straight, and 
joints limber (Brennan, 2015).  Nursing 
professionals should also teach the 
importance of a balanced healthy diet; 
this prevents weight problems from 
having additional effects on the 
underlying disease process of DMD 
(Brennan, 2015).   
     All of these things along with medical 
management improve the outlook of life 
for these individuals. Because life 
expectancies for children with DMD are 
increasing, growing recognition, within 
healthcare, of the need to support these 
individuals as they transition into adult 
life is being realized (Hamdani, Mistry, & 
Gibron, 2014). Today, many young adults 
living with DMD are able to attend 
college, have a career, and even start 
families (Brenan, 2015). 
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